ArticleJTO clinical and research reports2026
Organized Lung Cancer Screening of Subjects Occupationally Exposed to Lung Carcinogens: The LUng Cancer Screening Occupational exposure Study Entry Findings.
Article in JTO clinical and research reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The LUng Cancer Screening Occupational exposure (LUCSO) program was designed as a feasibility study of organized screening for lung cancer in subjects with occupational exposure to lung carcinogens in France. Herein, we report the program's entry-level (baseline) findings. Methods: The inclusion criteria were subjects aged 55 to 74 years, with sufficient exposure to International Agency for Research on Cancer group 1 occupational carcinogens and smoker or ex-smoker for less than 15 years. The first phase of the study addressed subjects aged 65 to 74 years in two French regional counties to test feasibility. Lung cancer screening was based on a low-dose computed tomography (CT) scan at baseline and spirometry, followed by an annual CT scan for 2 years and telephone follow-up at 3 years. Results: Letters were sent to 247,152 subjects from the Regional Cancer Screening Coordination Center inviting them to participate, allowing eligibility screening by letter. Among the 21,502 respondents (8.7%), 311 (1.4%) were included. Asbestos exposure predominated (92%), but co-exposures were also frequent (73% crystalline silica and 48% welding fumes); 45% were active smokers at inclusion, and 37% of them agreed to consult a smoking-cessation specialist. Baseline CT scans revealed anomalies in 19 (6.1%); seven (2.4%) were diagnosed with the following stages of lung cancer: three stage IA, three stage IIA, and one stage IIB; the false-positive rate was 4.2%. Conclusion: Before considering nationwide implementation, this feasibility study provided new real-life insights finding that the selected population was indeed at high risk of lung cancer and that screening effectively detected early stages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.